Stock Report

Download full stock data and analysis for free Last Updated: 29-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Dr. Lal Pathlabs Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: LALPATHLAB | BSE: 539524

₹1,931.10

up-down-arrow ₹-5.30 (-0.27%)

As on 28-Aug-2026IST

Market cap

info icon

₹32,407 Cr

Revenue (TTM)

info icon

₹2,891 Cr

P/E Ratio

info icon

59.8

P/B Ratio

info icon

12.4

Div. Yield

info icon

1.1 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 13.52 19.10 14.29 12.04 8.51
EBIT 42.83 28.79 15.64 21.74 5.97
Net Profit 29.09 28.02 9.88 28.81 7.41
EPS 29.09 28.02 5.43 26.92 6.43
Book Value -- -- 15.15 14.76 15.05
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-26Mar-25
EBIT-Margin info 22.0620.8823.0422.4722.49
Net Margin info 18.1416.1918.2317.8019.27
Return on equity info 23.0522.2123.0322.3725.15
Return on Capital info 29.4828.40--29.5631.53
Return on Assets info 18.0416.1618.6417.9219.53
Debt to Equity (x) info ----0.000.000.00

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
29.56
31.53
27.89
20.34
Peer Median
--
19.91
20.26
19.83
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

23.03

Higher than Peers by 7.96

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
23.03
22.37
25.15
21.27
15.80
Peer Median
15.08
15.24
13.93
15.80
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

18.64

Higher than Peers by 8.14

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
18.64
17.92
19.53
15.23
10.36
Peer Median
10.50
9.56
10.00
8.30
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

23.04

Higher than Peers by 4.30

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
23.04
22.47
22.49
20.91
16.84
Peer Median
18.74
20.56
19.66
18.70
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

18.23

Higher than Peers by 4.42

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
18.23
17.80
19.27
15.78
11.71
Peer Median
13.82
11.77
11.96
12.26
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
24.31
25.76
22.72
19.40
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

14.29

Lower than Peers by 1.12

Year on year growth in net sales

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
14.29
12.25
10.54
10.40
-3.38
Peer Median
15.41
21.53
15.74
13.67
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

15.64

Lower than Peers by 1.50

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
15.64
12.11
18.90
37.10
-24.96
Peer Median
17.14
23.64
22.60
11.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

9.88

Lower than Peers by 10.11

Year on year growth in profit after tax

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
9.88
3.56
35.87
50.28
-31.18
Peer Median
19.99
22.94
23.29
9.39
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

5.43

Lower than Peers by 6.91

Year on year growth in earnings per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
5.43
3.39
35.99
49.58
-30.75
Peer Median
12.34
1.87
29.43
-7.32
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
15.41
17.68
11.82
11.41
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
--
--
0.05
0.15
Peer Median
--
0.02
0.05
0.08
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
--
--
--
0.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

3.48

Higher than Peers by 1.33

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
3.48
3.48
3.39
2.43
2.07
Peer Median
2.15
2.54
2.42
2.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

3.38

Higher than Peers by 1.36

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
3.38
3.38
3.30
2.35
2.00
Peer Median
2.02
2.57
2.37
2.33
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

30.37

Higher than Peers by 20.11

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
30.37
30.35
29.01
18.22
10.16
Peer Median
10.26
7.95
7.61
10.16
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

3.83

Lower than Peers by 5.50

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
3.83
4.01
3.58
3.48
3.51
Peer Median
9.33
9.37
10.62
7.60
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.99

Higher than Peers by 0.22

Sales / Average Total Assets

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
0.99
0.97
0.98
0.94
0.87
Peer Median
0.77
0.87
0.81
0.77
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
13.13
12.27
12.15
14.14
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
5.28
5.45
5.83
7.81
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
118.67
134.04
138.53
123.86
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
--
-100.26
-116.32
-120.56
-101.91
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

59.80

Lower than Peers by 0.70

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
59.80
43.61
21.26
26.40
31.90
Peer Median
60.50
65.79
59.48
60.28
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

12.40

Higher than Peers by 2.79

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
12.40
9.01
9.79
10.50
9.48
Peer Median
9.62
8.89
9.63
8.84
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

1.06

Higher than Peers by 0.71

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
1.06
1.56
0.97
1.06
0.66
Peer Median
0.35
0.14
0.04
0.42
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

33.41

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
33.41
23.88
25.19
26.74
27.86
Peer Median
--
48.88
48.17
47.88
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

32,407

Higher than Peers by 17,453

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-26
Mar-25
Mar-24
Mar-23
Dr. Lal Pathlabs
32,407
22,015
20,715
18,888
15,239
Peer Median
14,953
12,422
8,622
9,694
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...